Specialised team, shared expertise.
JustSpinouts is the spinout-focused arm of JustPartnering – created to help universities and research organisations accelerate commercialisation through spinouts leveraging the same trusted expertise that powers our partnering work.
Our spinout team is led by three seasoned professionals supported by a global network of domain-specific expert advisors and consultants to ensure every project is guided by relevant, real-word experience.
Together, we bring structure, direction, and commercial focus to help TTOs turn discoveries into successful companies.
Dr. Janette Dixon
Founder & Director
With over 25 years of experience in chief executive and consultancy roles across biotechnology, pharmaceuticals, and clinical diagnostics, Janette has been instrumental in driving strategic partnerships and out-licensing activities for numerous life sciences companies and academic groups.
Her doctoral research focused on understanding commercialisation strategy in biotech start-ups, providing unique insights into the relationships between technologies, business models and the impacts of these on partnering. As a serial entrepreneur, and founder of six biotech companies, Janette appreciates the challenges facing biotech CEOs in financing research and managing returns to shareholders.
Dr. Peter Kelly
Principal and CMC Consultant
Peter specialises in driving the transition of programs from research to early-stage clinical development, including drug repurposing programs. He has held management roles in life science startups as well as contract development and manufacturing organizations (CDMOs).
His experience includes production of drugs via chemical synthesis and production of drugs using biotechnology. He holds an MBA, a DPhil in Organic Chemistry, and a Project Management qualification (PMP).
Ms. Fiona Seddon
Regulatory Consultant
Fiona has more than 25 years of experience in alignment of product development with regulatory compliance for achieving development milestones in regulatory approvals.
Her experience includes scientific and regulatory roles in CSL/Seqirus and regulatory consulting where she has worked closely with the product development, manufacturing and analytical teams supported by her strong background in biochemistry and microbiology. Fiona’s regulatory experience include successful submissions for clinical trial applications, drug master files, orphan drug designation and product registration dossiers.
Our global advisor network.
To support the diverse scientific, regulatory, and commercial needs of each spinout, we’re building a global network of specialist advisors with deep, domain-specific experience. These advisors bring real-world insight from pharma, biotech, venture groups, and translational research – ensuring every project is informed by people who’ve lived the challenges our spinouts are navigating.
We’re actively growing this network.
Ask us about the current composition of our advisors and how we select specialists for each project.
Expert help,
without the overhead.
50+
Assets supported.
We've helped transition >50 candidates from the lab to the clinic.
3k+
Global investor & partner contacts.
Direct access to biotechs and investors across pharma, biotech, medtech, and animal health.
100s
Years of experience.
Small team with deep experience in drug development and spinout creation.